These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22998215)

  • 1. Pharmacokinetic properties, potential herb-drug interactions and acute toxicity of oral Rhizoma coptidis alkaloids.
    Ma BL; Ma YM
    Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):51-61. PubMed ID: 22998215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influences of Fructus evodiae pretreatment on the pharmacokinetics of Rhizoma coptidis alkaloids.
    Ma BL; Yao MK; Han XH; Ma YM; Wu JS; Wang CH
    J Ethnopharmacol; 2011 Oct; 137(3):1395-401. PubMed ID: 21855623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide increased the acute toxicity of the Rhizoma coptidis extract in mice by increasing the systemic exposure to Rhizoma coptidis alkaloids.
    Ma BL; Ma YM; Gao CL; Wu JS; Qiu FR; Wang CH; Wang XH
    J Ethnopharmacol; 2011 Oct; 138(1):169-74. PubMed ID: 21924335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the toxic constituents in Rhizoma Coptidis.
    Ma BL; Ma YM; Shi R; Wang TM; Zhang N; Wang CH; Yang Y
    J Ethnopharmacol; 2010 Mar; 128(2):357-64. PubMed ID: 20117200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased systemic exposure to rhizoma coptidis alkaloids in lipopolysaccharide-pretreated rats attributable to enhanced intestinal absorption.
    Ma BL; Yao MK; Zhong J; Ma YM; Gao CL; Wu JS; Qiu FR; Wang CH; Wang XH
    Drug Metab Dispos; 2012 Feb; 40(2):381-8. PubMed ID: 22086980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites of protoberberine alkaloids in human urine following oral administration of Coptidis Rhizoma decoction.
    Yang Y; Kang N; Xia H; Li J; Chen L; Qiu F
    Planta Med; 2010 Nov; 76(16):1859-63. PubMed ID: 20549593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of pharmacokinetic studies on herbal drug Fuzi: Implications for Fuzi as personalized medicine.
    Wu JJ; Guo ZZ; Zhu YF; Huang ZJ; Gong X; Li YH; Son WJ; Li XY; Lou YM; Zhu LJ; Lu LL; Liu ZQ; Liu L
    Phytomedicine; 2018 May; 44():187-203. PubMed ID: 29526584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro inhibition of Huanglian [Rhizoma coptidis (L.)] and its six active alkaloids on six cytochrome P450 isoforms in human liver microsomes.
    Han YL; Yu HL; Li D; Meng XL; Zhou ZY; Yu Q; Zhang XY; Wang FJ; Guo C
    Phytother Res; 2011 Nov; 25(11):1660-5. PubMed ID: 21425377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on intestinal absorption and pharmacokinetic characterization of diester diterpenoid alkaloids in precipitation derived from fuzi-gancao herb-pair decoction for its potential interaction mechanism investigation.
    Zhang JM; Liao W; He YX; He Y; Yan D; Fu CM
    J Ethnopharmacol; 2013 May; 147(1):128-35. PubMed ID: 23506993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailabilty and pharmacokinetics of four active alkaloids of traditional Chinese medicine Yanhuanglian in rats following intravenous and oral administration.
    Li HL; Zhang WD; Zhang C; Liu RH; Wang XW; Wang XL; Zhu JB; Chen CL
    J Pharm Biomed Anal; 2006 Jun; 41(4):1342-6. PubMed ID: 16644173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory activities of the alkaloids from Coptidis Rhizoma against aldose reductase.
    Jung HA; Yoon NY; Bae HJ; Min BS; Choi JS
    Arch Pharm Res; 2008 Nov; 31(11):1405-12. PubMed ID: 19023536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rutaecarpine effects on expression of hepatic phase-1, phase-2 metabolism and transporter genes as a basis of herb-drug interactions.
    Zhu QN; Zhang D; Jin T; Wu Q; Liu J; Lu YF
    J Ethnopharmacol; 2013 May; 147(1):215-9. PubMed ID: 23510861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved?
    Yu S; Yu Y; Liu L; Wang X; Lu S; Liang Y; Liu X; Xie L; Wang G
    Planta Med; 2010 Jun; 76(9):876-81. PubMed ID: 20108175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of herb-drug metabolic interactions: a simulation study.
    Zhou S; Huang M; Xu A; Yang H; Duan W; Paxton JW
    Phytother Res; 2005 Jun; 19(6):464-71. PubMed ID: 16114078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo identification of metabolites of magnoflorine by LC LTQ-Orbitrap MS and its potential pharmacokinetic interaction in Coptidis Rhizoma decoction in rat.
    Xue B; Zhao Y; Miao Q; Miao P; Yang X; Sun G; Su J; Ye J; Wei B; Zhang Y; Zhang Y
    Biomed Chromatogr; 2015 Aug; 29(8):1235-48. PubMed ID: 25611590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic herb-drug interactions: are preventive screenings necessary and appropriate?
    Butterweck V; Derendorf H; Gaus W; Nahrstedt A; Schulz V; Unger M
    Planta Med; 2004 Sep; 70(9):784-91. PubMed ID: 15386186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic mechanisms underlying the detoxification effect of Glycyrrhizae Radix et Rhizoma (Gancao): drug metabolizing enzymes, transporters, and beyond.
    Li N; Zhou T; Wu F; Wang R; Zhao Q; Zhang JQ; Yang BC; Ma BL
    Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):167-177. PubMed ID: 30582378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety evaluation of main alkaloids from Rhizoma Coptidis.
    Yi J; Ye X; Wang D; He K; Yang Y; Liu X; Li X
    J Ethnopharmacol; 2013 Jan; 145(1):303-10. PubMed ID: 23159469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
    Etheridge AS; Black SR; Patel PR; So J; Mathews JM
    Planta Med; 2007 Jul; 73(8):731-41. PubMed ID: 17611934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution and pharmacokinetic properties of alkaloids and flavonoids in a Xiexin multiple-unit drug delivery system.
    Xie Y; Hu Y; Shen M; Ma Y; Zhong J; Zhang N; Tao J; Wei L
    Drug Res (Stuttg); 2013 Oct; 63(10):501-9. PubMed ID: 23756913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.